Cilostazol suppresses angiotensin II-induced apoptosis in endothelial cells

Patients with essential hypertension undergo endothelial dysfunction, particularly in the conduit arteries. Cilostazol, a type III phosphodiesterase inhibitor, serves a role in the inhibition of platelet aggregation and it is widely used in the treatment of peripheral vascular diseases. Previous stu...

Descripción completa

Detalles Bibliográficos
Autores principales: SHI, MIAO-QIAN, SU, FEI-FEI, XU, XUAN, LIU, XIONG-TAO, WANG, HONG-TAO, ZHANG, WEI, LI, XUE, LIAN, CHENG, ZHENG, QIANG-SUN, FENG, ZHI-CHUN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768974/
https://www.ncbi.nlm.nih.gov/pubmed/26862035
http://dx.doi.org/10.3892/mmr.2016.4881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768974/
https://www.ncbi.nlm.nih.gov/pubmed/26862035
http://dx.doi.org/10.3892/mmr.2016.4881

Ejemplares similares